This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
DALLAS, March 27, 2025 More than 56 million people globally live with heartfailure (HF), which prevents the body from getting enough of the oxygen-rich blood it needs to work properly.[1] 1] While there is no cure for HF, many people with this.
Cambridge, MA-based artificial intelligence (AI)-driven health technology company, Anumana, has announced its receipt of the International Organization for Standardization (ISO) 13485 certification for its Quality Management System. ECG-AI LEF, the company’s breakthrough AI algorithm, received U.S.
ECG machine certification is crucial in achieving these goals and building trust among healthcare providers and patients. In this blog, we will explore the significance of ECG machine certification, the standards involved, data security measures, and the benefits it offers to manufacturers, healthcare providers, and patients.
A diverse range of stakeholders, including cardiologists, other health care professionals, cardiovascular patients, cardiovascular organizations, and the public are invited to share their perspectives on the new Board, including whether it meets the ABMS requirements for both initial certification and continuing competency.
The Cardiovascular Disease Maintenance of Certification Exam can be difficult, with a pass rate in 2021 of 88%. In early 2022, the ABIM updated its fee structure to help physicians pay less over time to maintain their certifications. What are some things you need to know before you sit for the exam? How much does the exam cost?
The core curriculum aims at promoting standardization and harmonization of training and evaluation in cardio-oncology, while it further provides the ground for an ESC certification programme designed to recognize the competencies of certified specialists.
Circulation: HeartFailure, Ahead of Print. Background:Mavacamten is the only cardiac myosin inhibitor approved by the US FDA for treatment of symptomatic New York Heart Association class II-III obstructive hypertrophic cardiomyopathy (HCM) patients. were women; 64.6% were >60 years of age. were women; 64.6%
This certification is known to be one of the harder ones, with a pass rate of 88% in 2021 , so don’t procrastinate studying. HeartFailure and Cardiomyopathy 19% Valvular Disease 15% Pericardial Disease 3% Congenital Heart Disease 3% Vascular Diseases 5% Systemic Hypertension and Hypotension 8.5%
Our study aims to analyze trends in hypertensive heart disease and hypertensive heart and kidney disease-related mortality in the United States, focusing on different races.Method:We retrieved death certificate data from the CDC-WONDER database for adults aged ≥25 years. The overall AAMR of 1.4 AAPC: 5.2,
They also noted that most cardiovascular deaths (n=372/491; 75.8%) were classified as ‘other cardiovascular death’, not as myocardial infarctions or congestive heartfailure, which typically predominate among cardiovascular deaths.
Aims There are no studies on the association between secondhand smoke (SHS) exposure and incident heartfailure (HF). HF events were verified by medical records or death certificates and ascertained from baseline through 2019. A cohort subset of 3376 non-active smoking participants underwent urinary cotinine measurements.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content